Detectable expression levels of CD137 on blood and tumor CD8+ T lymphocytes (and to a lesser extent in CD4+ T cells) at diagnosis were correlated to response to combined anti-PD-1/CTLA-4 mAbs (Fig. 7b, c, e, f). The gene discussed is CD4; the disease is neoplasm.